The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
MIM PHARMA
Oslo, Norway
A
11-50 Employees
2013
Key takeaway
MIM Pharma is a science-driven biopharmaceutical company focused on innovative medical solutions that enhance human health. They have developed a natural plant-based antiviral and immune-enhancing treatment targeting COVID-19 and influenza, backed by a strong research team and advanced technology.
Reference
Core business
MIM PHARMA
Bioinvent International AB
Rana, Norway
A
1-10 Employees
2018
Key takeaway
BioInvent is a clinical-stage biopharmaceutical company focused on discovering and developing antibody-based immunotherapies for cancer, particularly targeting hematological cancers and solid tumors. With a promising pipeline and strong industry partnerships, BioInvent is well-positioned to contribute to the expanding market for innovative cancer treatments.
Reference
Product
n-CoDeR | BioInvent
AlgiPharma
Sandvika, Norway
A
11-50 Employees
2006
Key takeaway
AlgiPharma is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutic options using its proprietary alginate technology. Their focus on addressing unmet medical needs, particularly in areas like cystic fibrosis, highlights their commitment to improving drug delivery and healthcare through advanced research and development.
Reference
Product
Technology - AlgiPharma
AlgiPharma's alginate oligomers normalize cystic fibrosis sputum, disrupt biofilms and reduce bacterial virulence
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Diatec Monoclonals AS
Oslo, Norway
A
51-100 Employees
1988
Key takeaway
Curida Diatec is a biotechnology company with over 25 years of experience in antibody production and conjugation, operating under ISO 9001 and GMP standards to ensure high-quality biopharmaceutical products.
Reference
Core business
GMP Site - Curida Diatec
Arctic Bioscience
Ørsta, Norway
A
11-50 Employees
2011
Key takeaway
Arctic Bioscience is a Norwegian biotechnology company focused on developing, manufacturing, and marketing pharmaceutical ingredients derived from natural marine membrane lipids. Their mission is to provide effective therapies for autoimmune disorders through innovative bioactive marine compounds.
Reference
Core business
Arctic Bioscience - Norwegian herring caviar extracts
Who we are We are a Norwegian biotechnology company developing, manufacturing and marketing pharmaceutical and nutraceutical ingredients based on natural
Neomed Management
Oslo, Norway
A
1-10 Employees
1997
Key takeaway
NeoMed Management is an investment firm that focuses exclusively on the healthcare industry, including biopharmaceuticals. The company invests in emerging companies that are developing innovative medical products, addressing significant market opportunities in pharmaceuticals.
Reference
Core business
Neomed - Homepage
BerGenBio
Bergen, Norway
A
11-50 Employees
2007
Key takeaway
BerGenBio is a clinical-stage biopharmaceutical company focused on developing innovative drugs for aggressive diseases like cancer and severe respiratory infections. The company is advancing a pipeline of selective AXL inhibitors, including bemcentinib and tilvestamab, and has established strategic partnerships to enhance its research and development efforts.
Reference
Core business
Partnering - BerGenBio
ClexBio
Oslo, Norway
A
1-10 Employees
2020
Key takeaway
ClexBio is a pre-clinical stage regenerative medicine company that focuses on innovative tissue engineering solutions. Their proprietary technology platform enables scalable and high-throughput tissue generation, which is highly relevant to the biopharmaceutical field.
Reference
Core business
ClexBio | Engineering Human Tissue Transplants
ClexBio is a biotech company creating innovative solutions for tissue engineering and single-cell techniques using advanced microfluidics and the proprietary CLEX hydrogel technology.
Biovotec
Oslo, Norway
A
1-10 Employees
2015
Key takeaway
Biovotec is a Norwegian company focused on developing innovative technology solutions for wound care, including their novel medical device, DermaRep®, which utilizes Purified Eggshell Membrane Protein. Their commitment to addressing critical issues in healthcare through biomaterials positions them as a key player in the biopharmaceutical sector.
Reference
Core business
BIOVOTEC - Company founded in Norway in 2014 for wound healing...
Biovotec company is engaged in transforming future wound healing and other skin applications by using an innovative biomaterial...
PL+
Oslo, Norway
A
251-500 Employees
-
Key takeaway
Aker BioMarine is a biotech innovator that specializes in developing krill-based ingredients rich in phospholipids, which are essential for enhancing the absorption of dietary supplements. Their PL+ delivery platform utilizes a unique self-emulsifying system to improve the bioavailability of various compounds, including EPA-DHA, Curcumin, CoQ10, and CBD, ultimately aiming to boost their health benefits.
Reference
Core business
Phospholipid plus technology
Is a krill-based ingredient from Aker BioMarine a biotech innovator and global leader in marine phospholipids.
Technologies which have been searched by others and may be interesting for you:
When exploring the biopharmaceutical industry in Norway, several key considerations come into play. The country boasts a robust regulatory framework governed by the Norwegian Medicines Agency, ensuring compliance with European Medicines Agency standards. This creates a stable environment for companies but requires adherence to stringent regulations throughout the drug development process. The industry faces challenges such as high research and development costs and the need for innovative solutions to address complex health issues. However, there are significant opportunities as Norway invests in biotechnology, particularly in areas like personalized medicine and genomics, facilitated by strong academic and research institutions. Environmental concerns are increasingly relevant, with a focus on sustainable practices and reducing the ecological footprint of biopharmaceutical manufacturing. The competitive landscape includes both established companies and a growing number of startups, fostering innovation and collaboration. Additionally, the global market relevance of Norway's biopharmaceutical sector is enhanced by its strong export capabilities and partnerships within the European Union and beyond. Understanding these factors is crucial for anyone interested in entering or investing in Norway's biopharmaceutical industry, as they shape the operational landscape and future growth potential.
Some interesting numbers and facts about your company results for Biopharmaceutical
| Country with most fitting companies | Norway |
| Amount of fitting manufacturers | 23 |
| Amount of suitable service providers | 12 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1988 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Biopharmaceutical
What are related technologies to Biopharmaceutical?
Based on our calculations related technologies to Biopharmaceutical are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Biopharmaceutical?
The most represented industries which are working in Biopharmaceutical are Other, Biotechnology, IT, Software and Services, Healthcare, Medical
How does ensun find these Biopharmaceutical Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
